Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Bevacizumab active in pretreated ovarian cancer

March 6, 2007

Thalidomide Pharmion MAA accepted for review in E.U.

March 5, 2007

Quadramet studied with PSA-TRICOM for hormone-refractory prostate cancer

March 5, 2007

Sunesis files IND for Aurora kinase inhibitor SNS-314

March 5, 2007

Insert and R&D sign agreement on second-generation epothilones

March 5, 2007

Point Therapeutics advances talabostat studies

March 5, 2007

EvoGenix and Vegenics collaborate on VEGF-D antibody therapeutic products

March 5, 2007

Promising results for HE-32356 in mouse models of hormone-refractory prostate and breast cancer

March 5, 2007

Recent patents impart novel therapeutics for the treatment of cancer

March 5, 2007

Tykerb studied in phase III trial for head and neck cancer

March 2, 2007

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...